CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA), Inc.

1:16-cv-00924

Overview

Case Number 1:16-cv-00924
Filing Date 2016-10-11
Status Terminated
Termination Date 2019-09-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Cadila Healthcare Ltd. Operating Company

Represented By

5 Attorneys Listed

Michael J. Gaertner

Email: mgaertner@lockelord.com

Jennifer M. Coronel

Email: jennifer.coronel@lockelord.com

Emily L. Savas

Email: esavas@lockelord.com

Carolyn A. Blessing

Email: cblessing@lockelord.com

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Zydus Pharmaceuticals (USA), Inc. Operating Company

Represented By

6 Attorneys Listed

Michael J. Gaertner

Email: mgaertner@lockelord.com

Jennifer M. Coronel

Email: jennifer.coronel@lockelord.com

Emily L. Savas

Email: esavas@lockelord.com

David B. Abramowitz

Email: dabramowitz@lockelord.com

Carolyn A. Blessing

Email: cblessing@lockelord.com

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Plaintiff

Astellas Pharma Global Development, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Astellas Ireland Co., Ltd. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Astellas Pharma Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7342117
α-form or β-form crystal of acetanilide derivative
Filed: 2002-10-20
Issued: 2008-03-11
Expired (Term Ended) +371d PTA
Expires: 2023-10-26
US7982049
α-form or β-form crystal of acetanilide derivative
Filed: 2008-01-14
Issued: 2011-07-19
Expired (Term Ended)
Expires: 2026-04-07
US8835474
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
Filed: 2011-05-27
Issued: 2014-09-16
Active (4.5 yrs remaining)
Expires: 2031-05-27
USRE44872
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
Filed: 2003-11-04
Issued: 2014-04-29
Expired (Term Ended) +44d PTA
Expires: 2023-12-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+371 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 2 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Referred to Magistrate
ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: This case shall be immediately referred to Magistrate Judge Christopher ...
Entry #25 • 2017-08-10 Document →
Claim Construction / Markman Filing Pending
SO ORDERED, re (22 in 1:16-cv-00954-SLR, 25 in 1:16-cv-00908-SLR, 25 in 1:16-cv-00905-SLR, 21 in 1:16-cv-00976-SLR, 24 in 1:16-cv-00924-SLR, 26 in 1:16-cv-00942...
Entry #— • 2017-03-16
Procedural / Extension Motion Pending
SO ORDERED, re 16 STIPULATION TO EXTEND TIME for the defendants to respond to the complaint and for plaintiffs to answer, move or otherwise respond to any count...
Entry #— • 2017-01-04
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the defendants to respond to the complaint and for plaintiffs to answer, move or otherwise respond to any counterclaims to Januar...
Entry #16 • 2017-01-03 Document →

Docket Entries

(61 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA), Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2010690.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(nmg) (Entered: 10/12/2016)

Entry #1 • 2016-10-11
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 10/12/2016)

Entry #2 • 2016-10-11
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/7/2016. Date of Expiration of Patent: 11/4/2023.Thirty Month Stay Deadline: 12/28/2019. (nmg) (Entered: 10/12/2016)

Entry #3 • 2016-10-11
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E. (nmg) (Entered: 10/12/2016)

Entry #4 • 2016-10-11
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Astellas Pharma Inc. (nmg) (Entered: 10/12/2016)

Entry #5 • 2016-10-11
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc